News Headlines

  1. Catalent Invests $14M At Its Eberbach, Germany Softgel Facility
    4/23/2019

    Catalent, the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that work is underway to expand integrated turnkey softgel capabilities at its facility in Eberbach, Germany.

  2. Cambrex Completes New Quality Control Laboratory For Generic API Development In Milan
    4/23/2019

    Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, recently announced that it had opened a new 120m2 quality control (QC) laboratory at its site in Paullo, Milan, Italy.

  3. Biotechpharma To Expand Process Development And GMP Manufacturing Capacity To 5,000 L
    4/18/2019

    Biotechpharma UAB, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced further expansion of its fermentation capacity to 5,000 L, along with an additional state-of-the-art process development laboratory, investing more than €50 million in the expansion.

  4. Encube Ethicals Announces New High Potency Topical Manufacturing Suite
    4/17/2019

    Encube Ethicals, an integrated pharmaceutical organisation specialising in topical, transdermal and complex delivery solutions, has announced that its new high potency manufacturing facility for topical formulations is now fully operational.

  5. Surge Of Indian Biosimilars Market Forecast In 2019
    4/16/2019

    New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production.

  6. Catalent To Acquire Gene Therapy Leader Paragon Bioservices, Inc. For $1.2B
    4/15/2019

    Catalent, Inc., the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies, recently announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2B.

  7. Catalent Celebrates Opening Of Second Shanghai Facility To Optimize Global And Local Clinical Supply Solutions For China
    4/11/2019

    Catalent Pharma Solutions, a global leader in clinical supply services, recently announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China. The event was marked with an official opening ceremony at the site on April 10.

  8. Cambrex Completes Highly Potent API Manufacturing Facility At Charles City, IA
    4/10/2019

    Cambrex Corporation the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, recently announced that it had completed the construction of a $24M highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.

  9. Merck And NJII Receive NIIMBL Award For Biopharmaceutical Workforce Training Acceleration Project
    4/9/2019

    The New Jersey Innovation Institute (NJII), an NJIT Corporation, and Merck have been awarded a Biopharmaceutical Workforce Training Acceleration Project by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute designed to advance biopharmaceutical manufacturing in the U.S.

  10. GeneDesign Joins Ajinomoto Bio-Pharma Services And Opens Oligonucleotide API Development Center
    4/8/2019

    Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.